TEVA - CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday | Benzinga
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Keybanc raised Synopsys, Inc. (NASDAQ: SNPS) price target from $540 to $600. Keybanc analyst Jason Celino maintained an Overweight rating. Synopsys shares rose 0.3% to close at $542.69 on Friday. See how other analysts view this stock.
- Berenberg cut the price target for Corteva, Inc. (NYSE: CTVA) from $63 to $52. Berenberg analyst Aron Ceccarelli downgraded the stock from Buy to Hold. Corteva shares rose 0.7% to close at $46.67 on Friday. See how other analysts view this stock.
- UBS increased the price target for Teva Pharmaceutical Industries Limited (NYSE: TEVA) from $11 to $13. UBS analyst Ashwani Verma upgraded the stock from Neutral to Buy. Teva Pharmaceutical shares gained 2% to $9.74 in ...